ASHTON CHASE: Open Payments
NPI 1487202099 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$65,058 in 235 payments from 14 companies in 2025. Trend: 2023 $4,538 · 2024 $15,601 · 2025 $65,058
Speaker / faculty: $37,360Travel & lodging: $14,994Consulting: $6,450Food & beverage: $6,254
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 133 | $49,652 |
| ABBVIE INC. | 36 | $9,281 |
| ViiV Healthcare Company | 47 | $5,586 |
| ABIOMED | 1 | $142 |
| Merck Sharp & Dohme LLC | 5 | $135 |
| Lundbeck LLC | 4 | $79 |
| Hologic Sales and Service, LLC | 2 | $47 |
| Exact Sciences Corporation | 1 | $27 |
| Napo Pharmaceuticals Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
Products named: Yeztugo, Epclusa, MAVYRET, Descovy, DOVATO, Biktarvy, APRETUDE, CABENUVA.
Industry payments across CA — which companies pay providers there.
